630 related articles for article (PubMed ID: 12715099)
1. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant human interleukin-10 inhibits vascular smooth muscle cell proliferation induced by TNF-alpha].
OuYang P; Peng LS; Yang H; Wu WY; Xu AL
Sheng Li Xue Bao; 2002 Feb; 54(1):79-82. PubMed ID: 11930247
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of n-butylidenephthalide on neointimal hyperplasia in balloon injured rat carotid artery.
Liu WS; Lin PC; Chang LF; Harn HJ; Shiuan D; Chiou TW; Jeng JR
Phytother Res; 2011 Oct; 25(10):1494-502. PubMed ID: 21365711
[TBL] [Abstract][Full Text] [Related]
4. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
Guan S; Tang Q; Liu W; Zhu R; Li B
Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
[TBL] [Abstract][Full Text] [Related]
5. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits phenotypic switching of neointimal vascular smooth muscle cells after balloon injury through blockade of Notch pathway.
Zhang J; Chen J; Xu C; Yang J; Guo Q; Hu Q; Jiang H
J Cardiovasc Pharmacol; 2014 Mar; 63(3):233-9. PubMed ID: 24603118
[TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenols inhibit advanced glycation end product-induced rat vascular smooth muscle cell proliferation.
Ouyang P; Peng WL; Xu DL; Lai WY; Xu AL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):247-51. PubMed ID: 15041533
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.
Larifla L; Déprez I; Pham I; Rideau D; Louzier V; Adam M; Eloit M; Foucan L; Adnot S; Teiger E
J Gene Med; 2012 Jul; 14(7):459-67. PubMed ID: 22645072
[TBL] [Abstract][Full Text] [Related]
10. DNA aptamer raised against advanced glycation end products inhibits neointimal hyperplasia in balloon-injured rat carotid arteries.
Ojima A; Oda E; Higashimoto Y; Matsui T; Yamagishi S
Int J Cardiol; 2014 Feb; 171(3):443-6. PubMed ID: 24439773
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.
Maffia P; Grassia G; Di Meglio P; Carnuccio R; Berrino L; Garside P; Ianaro A; Ialenti A
Circulation; 2006 Aug; 114(5):430-7. PubMed ID: 16864728
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation.
Yang X; Thomas DP; Zhang X; Culver BW; Alexander BM; Murdoch WJ; Rao MN; Tulis DA; Ren J; Sreejayan N
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):85-90. PubMed ID: 16239599
[TBL] [Abstract][Full Text] [Related]
13. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
14. The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.
Roubille F; Busseuil D; Shi Y; Nachar W; Mihalache-Avram T; Mecteau M; Gillis MA; Brand G; Théberge-Julien G; Brodeur MR; Kernaleguen AE; Gombos M; Rhéaume E; Tardif JC
Atherosclerosis; 2014 Oct; 236(2):277-85. PubMed ID: 25108619
[TBL] [Abstract][Full Text] [Related]
15. [Green tea polyphenols inhibit low-density lipoprotein-induced proliferation of rat vascular smooth muscle cells].
Ouyang P; Peng WL; Lai WY; Xu AL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):975-9. PubMed ID: 15447839
[TBL] [Abstract][Full Text] [Related]
16. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway.
Li X; Du JR; Yu Y; Bai B; Zheng XY
J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310
[TBL] [Abstract][Full Text] [Related]
18. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery.
Han Y; Deng J; Guo L; Yan C; Liang M; Kang J; Liu H; Graham AM; Li S
Cardiovasc Res; 2008 Jun; 78(3):597-604. PubMed ID: 18267954
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.
Hlawaty H; Suffee N; Sutton A; Oudar O; Haddad O; Ollivier V; Laguillier-Morizot C; Gattegno L; Letourneur D; Charnaux N
Biochem Pharmacol; 2011 Jan; 81(2):233-43. PubMed ID: 20887714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
